The emerging approach of tirzepatide peptide represents a major advance in the management of the condition. Unlike existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide206849.blogvivi.com/42608041/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment